“Cannabinoids show promising potential in managing symptoms such as agitation and aggression in people with dementia, with an overall favorable safety and tolerability profile,” investigators concluded.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“These results support the hypothesis that different cannabinoids may exert distinct roles in modulating sleep-related therapeutic benefits,” researchers reported.
“The mere odor of cannabis standing alone no longer can make it clearly or immediately apparent that the substance is contraband,” the majority ruled.
“The Missouri Supreme Court majority is clearly substituting its personal preferences for the will of the voters as expressed in the plain language of the initiative,” Missouri NORML’s Dan Viets said.
Over 56 percent of respondents acknowledged consuming either “slightly less” or “much less” alcohol after trying cannabis-infused beverages.
Compared to those receiving the placebo, patients receiving cannabis extracts demonstrated significant improvements in pain intensity, sleep quality, physical function, and overall quality of life.
“Approximately one in five older Canadians reported using cannabis, at least in part, to manage mental health symptoms,” investigators reported.
The study’s authors cautioned against relying on ocular measures as evidence of cannabis-induced impairment, suggesting that the tests lacked the accuracy and specificity necessary to be a valid evidentiary tool.